Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Price / Earnings (ltm)

Aerie Pharmaceuticals Price / Earnings (ltm) Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Price / Earnings (ltm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Aerie Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $2,142m a 11.86% increase of 254m year over year
  • Aerie Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 14.78 a -42.15% decrease of -6.23 year over year
  • Aerie Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $2,017m a 10.53% increase of 212m year over year
View Chart On Koyfin